Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | TPMT | P51580 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | INSR | P06213 | 1/20 | 0.33 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27628106 | 0.83 | CA2 (0.43) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL31015964 | 0.82 | CA2 (0.41) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL5208683 | 0.82 | CA2 (0.41) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL9377977 | 0.82 | CA2 (0.41) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL24638840 | 0.81 | CA2 (0.42) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL30407185 | 0.81 | CA2 (0.42) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL9804695 | 0.81 | CA2 (0.42) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL3841844 | 0.81 | CA2 (0.42) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL29824773 | 0.81 | CA2 (0.42) | CA2CA4HSD17B10ALOX5APFEN1 | |
| SCHEMBL31075908 | 0.78 | CA2 (0.43) | CA2CA4HSD17B10ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100500629-C | Method for preparing 2-Methyl-1[4-(trifluoromethoxy)phenyl] propan-1-one | SHANGHAI WANKAI CHEMICAL CO LT (CN) | 2009-06-17 | — | — | CN | claimed |
| CN-101100417-A | Method for preparing 2-Methyl-1[4-(trifluoromethoxy)phenyl] propan-1-one | SHANGHAI FINE CHEMICAL CO LTD (CN) | 2008-01-09 | — | — | CN | claimed |
| CN-108752287-A | The preparation method and purposes of heterocycle tertiary alcohol derivative | 南开大学 | 2018-11-06 | — | — | CN | disclosed |
| CN-101792377-B | Preparation method of 3,5-difluoro-4-trifluoro-methoxyl bromobenzene | ZHEJIANG YONGTAI TECHNOLOGY CO LTD | 2012-01-25 | — | — | CN | disclosed |
| CN-101792377-A | Preparation method of 3,5-difluoro-4-trifluoro-methoxyl bromobenzene | ZHEJIANG YONGTAI TECHNOLOGY CO LTD | 2010-08-04 | — | — | CN | disclosed |
| CN-100500629-C | Method for preparing 2-Methyl-1[4-(trifluoromethoxy)phenyl] propan-1-one | SHANGHAI WANKAI CHEMICAL CO LT (CN) | 2009-06-17 | — | — | CN | disclosed |
| US-7425566-B2 | 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them | SANOFI-AVENTIS (FR) | 2008-09-16 | — | — | US | disclosed |
| CN-101100417-A | Method for preparing 2-Methyl-1[4-(trifluoromethoxy)phenyl] propan-1-one | SHANGHAI FINE CHEMICAL CO LTD (CN) | 2008-01-09 | — | — | CN | disclosed |
| CN-1812790-A | 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor | WYETH CORP (US) | 2006-08-02 | — | — | CN | disclosed |
| US-20050176770-A1 | Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them | SANOFI-AVENTIS (FR) | 2005-08-11 | — | — | US | disclosed |
| CN-1147193-A | Insecticidal N-(substd. Arylmethyl)-4-[bis(substd. phenyl) methyl] piperidines | FMC CORP (US) | 1997-04-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176770-A1 | Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them | AVPR1B, AVPR2, AVPR1A | CA2 709/4885CA4 2661/4885HSD17B10 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.